Department of Veterinary and Biomedical Sciences, The Center of Molecular Toxicology and Carcinogenesis, The Pennsylvania State University, University Park, PA 16802, USA.
Cell Signal. 2011 Dec;23(12):2039-50. doi: 10.1016/j.cellsig.2011.07.020. Epub 2011 Aug 4.
Peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) function and receptor cross-talk with other nuclear receptors, including PPARγ and retinoic acid receptors (RARs), was examined using stable human HaCaT keratinocyte cell lines over-expressing PPARβ/δ or PPARγ. Enhanced ligand-induced expression of two known PPAR target genes, adipocyte differentiation-related protein (ADRP) and angiopoietin-like protein 4 (ANGPTL4), was found in HaCaT keratinocytes over-expressing PPARβ/δ or PPARγ. Over-expression of PPARβ/δ did not modulate the effect of a PPARγ agonist on up-regulation of ADRP or ANGPTL4 mRNA in HaCaT keratinocytes. All-trans retinoic acid (atRA) increased expression of a known RAR target gene, yet despite a high ratio of fatty acid binding protein 5 (FABP5) to cellular retinoic acid binding protein II, did not increase expression of ANGPTL4 or 3-phosphoinositide-dependent-protein kinase 1 (PDPK1), even in HaCaT keratinocytes expressing markedly higher levels of PPARβ/δ. While PPARβ/δ-dependent attenuation of staurosporine- or UVB-induced poly (ADP-ribose) polymerase (PARP) cleavage was not observed, PPARβ/δ- and PPARγ-dependent repression of UVB-induced expression and secretion of inflammatory cytokines was found in HaCaT keratinocytes over-expressing PPARβ/δ or PPARγ. These studies suggest that FABP5 does not transport atRA or GW0742 to PPARβ/δ and promote anti-apoptotic activity by increasing expression of PDPK1, or that PPARβ/δ interferes with PPARγ transcriptional activity. However, these studies demonstrate that stable over-expression of PPARβ/δ or PPARγ significantly increases the efficacy of ligand activation and represses UVB-induced expression of tumor necrosis factor α (TNFα), interleukin 6 (IL6), or IL8 in HaCaT keratinocytes, thereby establishing an excellent model to study the functional role of these receptors in human keratinocytes.
过氧化物酶体增殖物激活受体-β/δ(PPARβ/δ)的功能及其与其他核受体(包括 PPARγ 和视黄酸受体(RARs))的受体交叉对话,使用稳定表达 PPARβ/δ 或 PPARγ 的人 HaCaT 角质形成细胞系进行了研究。发现过表达 PPARβ/δ 或 PPARγ 的 HaCaT 角质形成细胞中,两种已知的 PPAR 靶基因脂肪细胞分化相关蛋白(ADRP)和血管生成素样蛋白 4(ANGPTL4)的配体诱导表达增强。过表达 PPARβ/δ 不会调节 PPARγ 激动剂对 HaCaT 角质形成细胞中 ADRP 或 ANGPTL4 mRNA 上调的作用。全反式视黄酸(atRA)增加了已知 RAR 靶基因的表达,但尽管脂肪酸结合蛋白 5(FABP5)与细胞视黄酸结合蛋白 II 的比例很高,但即使在表达明显更高水平的 PPARβ/δ 的 HaCaT 角质形成细胞中,也不会增加 ANGPTL4 或 3-磷酸肌醇依赖性蛋白激酶 1(PDPK1)的表达。虽然没有观察到 PPARβ/δ 依赖性抑制 staurosporine 或 UVB 诱导的多聚(ADP-核糖)聚合酶(PARP)切割,但在过表达 PPARβ/δ 或 PPARγ 的 HaCaT 角质形成细胞中,发现 PPARβ/δ 和 PPARγ 依赖性抑制 UVB 诱导的炎性细胞因子的表达和分泌。这些研究表明,FABP5 不会将 atRA 或 GW0742 转运至 PPARβ/δ,也不会通过增加 PDPK1 的表达来促进抗凋亡活性,或者 PPARβ/δ 干扰 PPARγ 的转录活性。然而,这些研究表明,稳定过表达 PPARβ/δ 或 PPARγ 可显著提高配体激活的功效,并抑制 HaCaT 角质形成细胞中 TNFα、IL6 或 IL8 的 UVB 诱导表达,从而建立了一个研究这些受体在人角质形成细胞中功能作用的优秀模型。